Civic Intelligence

Elle S Angels Foundation

EIN 87-2676025 • 501(c)3 • Langhorne, PA

Profile

Research for a cure for DIPG

43 Wheel CourtLanghorne, PA 19047

www.ellesangelsfoundation.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on the latest valid filing.

Source year 2024

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on the latest valid filing.

Source year 2024

Net Margin

81st percentile

29%

Higher net margin than 81% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Top Officer Pay

81st percentile

$0

Higher top officer pay than 81% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2024

Asset Growth

74th percentile

17%

Faster asset growth than 74% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

35th percentile

-19%

Faster revenue growth than 35% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / AssetsScore unavailable

Assets

Up

$255,191

Up $121,970 (+92%) from 2022

Liabilities

-

No earlier filing loaded for comparison.

Net Assets

Up

$255,191

Up $121,970 (+92%) from 2022

Operations
Liabilities / RevenueScore unavailableNet Margin81st percentile

Revenue

Down

$127,783

Down $49,271 (-28%) from 2022

Expenses

Up

$91,088

Up $16,035 (+21%) from 2022

Net Income

Down

$36,695

Down $65,306 (-64%) from 2022

Trend Graphs

Balance Sheet Trend

Asset Growth74th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$300K$200K$100K$0Assets 2022: $133,221Net Assets 2022: $133,2212022Assets 2024: $255,191Net Assets 2024: $255,1912024

Highlighted filing

2024

Assets$255,191
Liabilities-
Net Assets$255,191
Open 2024 Filing

Operations Trend

Revenue Growth35th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$200K$150K$100K$50K$0Revenue 2022: $177,054Expenses 2022: $75,053Net Income 2022: $102,0012022Revenue 2024: $127,783Expenses 2024: $91,088Net Income 2024: $36,6952024

Highlighted filing

2024

Revenue$127,783
Expenses$91,088
Net Income$36,695
Open 2024 Filing

Filings

Most recent year

2024 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$255,191
Liabilities
-
Net assets
$255,191
Revenue
$127,783
Expenses
$91,088
Net income
$36,695
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$2.55$2.55$1.28$0.91$0.37
2022Detailed filing. Detailed filing data is available for this year.$1.33$1.33$1.77$0.75$1.02
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
May 13, 2025
Return Version
2024v5.1
Gross Receipts
$127,783
Mission and Program Overview

Mission

Research for a cure for DIPG

Program Services

DescriptionGrantsExpenses
Dr. Michelle Monje - Stanford School of Medicine - Car T Cell Trial. The primary purpose of this study is to test whether GD2-CAR T cells can be successfully made from immune cells collected from children and young adults with H3K27M-mutant diffuse intrinsic pontine glioma DIPG or spinal H3K27M-mutant diffuse midline glioma DMG. H3K27Mmutant testing will occur as part of standard of care prior to enrollment.$25,000$25,000
Dr. Javad Nazarian - George Washington Cancer Center - Mapping DMG Response The overall objective of this project is to elucidate the genetics and epigenetics map of DMG resistance to therapy. We seek to define the cellular composition of treatment resistant tumors identify gene regulators of resistance phenotypes and correlate this with clinical covariates. Our rationale for these studies is to determine biomarkers of treatment sensitivity that will drive inclusion criteria in future clinical trials.$15,000$15,000
DIPG DMG nurse navigator program. My DIPG Navigator led by dedicated nurses with years of experience in pediatric oncology will empower patients and their families with the proper information and resources necessary to make the most-informed decisions throughout their cancer journey. This service is completely free for any family able to be treated in the United States.$5,000$5,000
Compensation and Service Providers
Top Officer Pay81st percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Derek CarusoCo-FounderPT$0--
Kristi CarusoCo-FounderPT$0--
Dustin CarusoCommunityPT$0--
Lindsay DavisFundraiserPT$0--
Ashley EvittsSecretaryPT$0--
Filing and Contact Details

Filer

Filer Name
Elle S Angels Foundation
EIN
87-2676025
In Care Of
% Derek Caruso
Address
43 Wheel Court, Langhorne, PA 19047

Signing Officer

Name
Derek Michael Caruso
Title
CoFounder
Signed
2025-05-13
Supplemental Narrative

Additional Explanations

Part I, line 10

“| Grants And Similar Amounts Paid:, Amount:| Car T Cell Therapy Grant for Dr. Michelle Monje, $25000| Dr. Javad Nazarian - George Washington Cancer Center - Mapping DMG Response, $15000| Tough2gether Tumor Board annual costs, $5000| DIPG DMG Nurse Navigator Program, $5000|”

Part I, line 16

“| Other Expenses:, Amount:| Expenses related to the Annual Elles Angels Golf Outing, $19730| Golf Course Expense for EAF outing, $15015| Expenses for 5K Annual Run, $3098| Cornhole Tournament Expenses - shirts, $1500| Race Shirts for 5K, $1745|”

Raw XML Appendix157 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0Derek Caruso
IRS990EZ/BooksInCareOfDetail/PhoneNum04847694931
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt043 Wheel Court
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0Langhorne
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0PA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd019047
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0218496
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0255191
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt0127783
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt036695
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0218496
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0255191
IRS990EZ/GainOrLossFromSaleOfAssetsAmt00
IRS990EZ/GrantsAndSimilarAmountsPaidAmt050000
IRS990EZ/GrossProfitLossSlsOfInvntryAmt00
IRS990EZ/GrossReceiptsAmt0127783
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0218496
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0255191
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0218496
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0255191
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt010
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt110
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt35
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt45
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Derek Caruso
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Kristi Caruso
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2Dustin Caruso
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3Lindsay Davis
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4Ashley Evitts
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0Co-Founder
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Co-Founder
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Community
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Fundraiser
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4Secretary
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt041088
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0Research for a cure for DIPG
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0Dr. Michelle Monje - Stanford School of Medicine - Car T Cell Trial. The primary purpose of this study is to test whether GD2-CAR T cells can be successfully made from immune cells collected from children and young adults with H3K27M-mutant diffuse intrinsic pontine glioma DIPG or spinal H3K27M-mutant diffuse midline glioma DMG. H3K27Mmutant testing will occur as part of standard of care prior to enrollment.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt1Dr. Javad Nazarian - George Washington Cancer Center - Mapping DMG Response The overall objective of this project is to elucidate the genetics and epigenetics map of DMG resistance to therapy. We seek to define the cellular composition of treatment resistant tumors identify gene regulators of resistance phenotypes and correlate this with clinical covariates. Our rationale for these studies is to determine biomarkers of treatment sensitivity that will drive inclusion criteria in future clinical trials.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt2DIPG DMG nurse navigator program. My DIPG Navigator led by dedicated nurses with years of experience in pediatric oncology will empower patients and their families with the proper information and resources necessary to make the most-informed decisions throughout their cancer journey. This service is completely free for any family able to be treated in the United States.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt025000
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt115000
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt25000
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt025000
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt115000
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt25000
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialEventsNetIncomeLossAmt00
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt091088
IRS990EZ/TotalProgramServiceExpensesAmt045000
IRS990EZ/TotalRevenueAmt0127783
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0www.ellesangelsfoundation.org
IRS990ScheduleA/First5Years170Ind0X
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt0127783
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt0157345
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt0177054
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt024457
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0486639
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus2YearsAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt00
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportTotal170Amt0486639
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus2YearsAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/TotalAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt0127783
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt0157345
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt0177054
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt024457
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0486639
IRS990ScheduleA/TotalSupportAmt0486639
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearMinus2YearsAmt00
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/TotalAmt00
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0| Grants And Similar Amounts Paid:, Amount:| Car T Cell Therapy Grant for Dr. Michelle Monje, $25000| Dr. Javad Nazarian - George Washington Cancer Center - Mapping DMG Response, $15000| Tough2gether Tumor Board annual costs, $5000| DIPG DMG Nurse Navigator Program, $5000|
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1| Other Expenses:, Amount:| Expenses related to the Annual Elles Angels Golf Outing, $19730| Golf Course Expense for EAF outing, $15015| Expenses for 5K Annual Run, $3098| Cornhole Tournament Expenses - shirts, $1500| Race Shirts for 5K, $1745|
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Part I, line 10
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Part I, line 16
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/PersonNm0Derek Michael Caruso
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0CoFounder
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-05-13
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0ELLE S ANGELS FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0ELLE
ReturnHeader/Filer/EIN0872676025
ReturnHeader/Filer/ForeignPhoneNum04847694931
ReturnHeader/Filer/InCareOfNm0% Derek Caruso
ReturnHeader/Filer/USAddress/AddressLine1Txt043 Wheel Court
ReturnHeader/Filer/USAddress/CityNm0Langhorne
ReturnHeader/Filer/USAddress/StateAbbreviationCd0PA
ReturnHeader/Filer/USAddress/ZIPCd019047
ReturnHeader/ReturnTs02025-05-12T16:47:22-04:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 501(c)3 • <$500k nonprofits